|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Reconciliation of net income to net cash provided by operating activities | |||||
| Deferred income taxes | |||||
| Depreciation and amortization of property and equipment | |||||
| Amortization of intangible assets | |||||
| Provision for credit losses | |||||
| Stock-based compensation | |||||
| Other, net | |||||
| Changes in assets and liabilities, net of effects of acquisitions | |||||
| Accounts receivable | |||||
| Deferred costs | |||||
| Other assets and liabilities | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Operating leases | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Acquisition of business, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Repurchases of common stock | |||||
| Net proceeds from exercise of options to purchase common stock | |||||
| Net proceeds from employee stock purchase plan activity | |||||
| Payments for contingent consideration | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign currency exchange rate changes | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for income taxes | |||||
| Contingent consideration related to acquisition | |||||
Loading...